Title | Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis. |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Gogokhia L, Buhrke K, Bell R, Hoffman B, D Brown G, Hanke-Gogokhia C, Ajami NJ, Wong MC, Ghazaryan A, Valentine JF, Porter N, Martens E, O'Connell R, Jacob V, Scherl E, Crawford C, W Stephens Z, Casjens SR, Longman RS, Round JL |
Journal | Cell Host Microbe |
Volume | 25 |
Issue | 2 |
Pagination | 285-299.e8 |
Date Published | 2019 02 13 |
ISSN | 1934-6069 |
Keywords | Animals, Bacteria, Bacteriophages, CD4-Positive T-Lymphocytes, Colitis, Ulcerative, Colorectal Neoplasms, Disease Models, Animal, Fecal Microbiota Transplantation, Gastrointestinal Microbiome, Humans, Interferon-gamma, Intestinal Mucosa, Mice, Mice, Inbred C57BL, Mice, Knockout, Pilot Projects, Prospective Studies, Specific Pathogen-Free Organisms |
Abstract | Bacteriophages are the most abundant members of the microbiota and have the potential to shape gut bacterial communities. Changes to bacteriophage composition are associated with disease, but how phages impact mammalian health remains unclear. We noted an induction of host immunity when experimentally treating bacterially driven cancer, leading us to test whether bacteriophages alter immune responses. Treating germ-free mice with bacteriophages leads to immune cell expansion in the gut. Lactobacillus, Escherichia, and Bacteroides bacteriophages and phage DNA stimulated IFN-γ via the nucleotide-sensing receptor TLR9. The resultant immune responses were both phage and bacteria specific. Additionally, increasing bacteriophage levels exacerbated colitis via TLR9 and IFN-γ. Similarly, ulcerative colitis (UC) patients responsive to fecal microbiota transplantation (FMT) have reduced phages compared to non-responders, and mucosal IFN-γ positively correlates with bacteriophage levels. Bacteriophages from active UC patients induced more IFN-γ compared to healthy individuals. Collectively, these results indicate that bacteriophages can alter mucosal immunity to impact mammalian health. |
DOI | 10.1016/j.chom.2019.01.008 |
Alternate Journal | Cell Host Microbe |
PubMed ID | 30763538 |
Grant List | / / Wellcome Trust / United Kingdom DP2 GM111099 / GM / NIGMS NIH HHS / United States R00 HL102228 / HL / NHLBI NIH HHS / United States R01 GM114817 / GM / NIGMS NIH HHS / United States R01 DK114252 / DK / NIDDK NIH HHS / United States DP2 AT008746 / AT / NCCIH NIH HHS / United States |